The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors - Marchand, Lucien; Disse, Emmanuel; Dalle, Stéphane; Reffet, Sophie; Vouillarmet, Julien; Fabien, Nicole; Thivolet, Charles; Cugnet-Anceau, Christine (Acta diabetologica, 2019)
Keywords: Apoptosis; Autoimmune Diseases - chemically induced; Autoimmune Diseases - epidemiology; Autoimmune Diseases - etiology; B7-H1 Antigen - antagonists & inhibitors; B7-H1 Antigen - immunology; Cell Cycle Checkpoints - drug effects; Cell Cycle Checkpoints - immunology; Cell death; CTLA-4 Antigen - antagonists & inhibitors; CTLA-4 Antigen - immunology; CTLA-4 protein; Diabetes; Diabetes mellitus; Diabetes mellitus (insulin dependent); Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Lipoatrophic - chemically induced; Diabetes Mellitus, Lipoatrophic - epidemiology; Diabetes Mellitus, Lipoatrophic - immunology; Diabetes Mellitus, Type 1 - chemically induced; Diabetes Mellitus, Type 1 - complications; Diabetes Mellitus, Type 1 - diagnosis; Diabetes Mellitus, Type 1 - epidemiology; Diabetes Mellitus, Type 2 - chemically induced; Diabetes Mellitus, Type 2 - diagnosis; Diabetes Mellitus, Type 2 - epidemiology; Diabetes Mellitus, Type 2 - immunology; Humans; Immune checkpoint inhibitors; Immunotherapy; Immunotherapy - adverse effects; Insulin; Internal Medicine; Lipoatrophy; Medicine; Medicine & Public Health; Metabolic Diseases; Oncology; Pancreatitis; PD-1 protein; PD-L1 protein; Phenotypes; Protein Kinase Inhibitors - adverse effects; Protein Kinase Inhibitors - therapeutic use; Review Article; Anti-PD-1; Diabetes mellitus; Anti-PD-L1; Autoimmune diabetes; Autoimmune generalised lipoatrophy; Beta cell pancreatic function; Autoimmune lipodystrophy; Exocrine pancreatic function; Immunotherapy; Programmed cell death-1 (PD-1); Immune checkpoint inhibitors side effects; Fulminant diabetes; Alpha cell pancreatic function; Programmed death ligand 1 (PD-L1); Pancreas volume; Autoimmune pancreatitis